CRA keen to work with China on variant busters
CRA keen to work with China on variant busters
Yang Xin: New vaccines on way
The Chulabhorn Royal Academy (CRA) has expressed an intent to cooperate with Chinese state-owned company Sinopharm in developing second and third generation vaccines against Covid-19.
The potential cooperation on vaccine development has been unveiled by acting Chinese Ambassador Yang Xin, Chargé d'Affaires of the Embassy of the People's Republic of China in Thailand.
Mr Yang said China is developing second and third generation vaccines targetting the Covid-19 variants and bilateral cooperation on vaccine development is on the cards.
He said the CRA, which procures the Sinopharm vaccine to supplement the government's vaccination drive, has expressed an intent to join hands with the firm in vaccine development.